KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

West Pharmaceutical Services (WST) FCF Payout Ratio (2016 - 2026)

West Pharmaceutical Services has reported FCF Payout Ratio over the past 18 years, most recently at 0.25 for Q1 2026.

  • Quarterly FCF Payout Ratio fell 5.34% to 0.25 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.13 through Mar 2026, up 28.03% year-over-year, with the annual reading at 0.13 for FY2025, 32.59% up from the prior year.
  • FCF Payout Ratio was 0.25 for Q1 2026 at West Pharmaceutical Services, up from 0.09 in the prior quarter.
  • Over five years, FCF Payout Ratio peaked at 0.26 in Q1 2025 and troughed at 0.29 in Q3 2024.
  • The 5-year median for FCF Payout Ratio is 0.12 (2022), against an average of 0.12.
  • Biggest five-year swings in FCF Payout Ratio: skyrocketed 211.75% in 2023 and later plummeted 375.98% in 2024.
  • Tracing WST's FCF Payout Ratio over 5 years: stood at 0.04 in 2022, then skyrocketed by 211.75% to 0.11 in 2023, then crashed by 67.06% to 0.04 in 2024, then skyrocketed by 141.47% to 0.09 in 2025, then skyrocketed by 174.29% to 0.25 in 2026.
  • According to Business Quant data, FCF Payout Ratio over the past three periods came in at 0.25, 0.09, and 0.11 for Q1 2026, Q4 2025, and Q3 2025 respectively.